Early Kidney Damage Markers after Deferasirox Treatment in Patients with Thalassemia Major: A Case-Control Study.
Badeli H, Baghersalimi A, Eslami S, Saadat F, Rad AH, Basavand R, Papkiadeh SR, Darbandi B, Kooti W, Peluso I.
Badeli H, et al.
Oxid Med Cell Longev. 2019 Apr 21;2019:5461617. doi: 10.1155/2019/5461617. eCollection 2019.
Oxid Med Cell Longev. 2019.
PMID: 31178966
Free PMC article.
METHOD: The present case-control study was conducted on 60 individuals who were referred to the 17th Shahrivar Tertiary Referral Hospital in Guilan province, Iran. In this study, patients with beta-thalassemia major who used deferasirox (n = 21) and patients who used defer …
METHOD: The present case-control study was conducted on 60 individuals who were referred to the 17th Shahrivar Tertiary Referral Hosp …